P-ANCA
P-ANCA[edit]
P-ANCA, or Perinuclear Anti-Neutrophil Cytoplasmic Antibodies, are a type of autoantibody primarily associated with certain types of vasculitis and other autoimmune diseases. These antibodies target proteins in the cytoplasm of neutrophils, a type of white blood cell.
Characteristics[edit]
P-ANCA is characterized by a staining pattern that is perinuclear, meaning that the fluorescence is concentrated around the nucleus of the neutrophils when viewed under a microscope. This pattern is typically observed using immunofluorescence techniques on ethanol-fixed neutrophils.
Associated Conditions[edit]
P-ANCA is most commonly associated with microscopic polyangiitis, eosinophilic granulomatosis with polyangiitis (formerly known as Churg-Strauss syndrome), and ulcerative colitis. It can also be found in other conditions such as primary sclerosing cholangitis and rheumatoid arthritis.
Microscopic Polyangiitis[edit]
Microscopic polyangiitis is a small-vessel vasculitis that often presents with renal involvement, such as glomerulonephritis, and pulmonary symptoms. P-ANCA is frequently detected in patients with this condition.
Eosinophilic Granulomatosis with Polyangiitis[edit]
Eosinophilic granulomatosis with polyangiitis is characterized by asthma, eosinophilia, and systemic vasculitis. P-ANCA is present in a significant number of patients with this disease.
Ulcerative Colitis[edit]
Ulcerative colitis is a form of inflammatory bowel disease that affects the colon and rectum. P-ANCA is often found in patients with ulcerative colitis, although its presence is not diagnostic of the disease.
Diagnostic Use[edit]
The presence of P-ANCA can aid in the diagnosis of certain autoimmune diseases, particularly when used in conjunction with clinical findings and other laboratory tests. It is important to note that P-ANCA is not specific to a single disease and can be found in various conditions.
Testing Methods[edit]
P-ANCA is typically detected using indirect immunofluorescence on ethanol-fixed neutrophils. The test involves incubating patient serum with neutrophils and then using a fluorescently labeled anti-human immunoglobulin to visualize the binding pattern.
